Silence Therapeutics News

F-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Oct 23 05:23

6-K: Report of foreign private issuer (related to financial reporting)

Aug 15 21:07

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invus Public Equities, L.P.(6.0%),Invus Public Equities Advisors, LLC(6.0%), etc.

Aug 3 06:54

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jun 27 19:42

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jun 24 20:40

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jun 20 20:42

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

May 18 05:09

6-K: Report of foreign private issuer (related to financial reporting)

May 17 02:26

EFFECT: Others

May 15 18:40

424B3: Prospectus

May 15 04:32

CORRESP: CORRESP

May 11 02:54

UPLOAD: Others

May 11 02:54

DEL AM: Others

May 9 05:20

F-3: Registration statement for specified transactions by certain foreign private issuers

May 8 05:08

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

May 2 04:42

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 29 20:38

Silence Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 15 19:03

Silence Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Richard Ian Griffiths(16.9%),Ora Capital Limited(7.8%)

Mar 28 05:10

Silence Therapeutics | 20-F: FY2023 Annual Report

Mar 13 20:58

Silence Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 13 19:13